At this time, there is no known cure for Pleuropulmonary blastoma type 2. Treatment typically involves a combination of chemotherapy, radiation therapy, and surgery. Medications used to treat this condition may include chemotherapy drugs, such as vincristine, doxorubicin, and cyclophosphamide, as well as targeted therapies, such as imatinib and sunitinib.

1. Young age: Pleuropulmonary blastoma type 2 is most commonly diagnosed in children under the age of 5.

2. Gender: Pleuropulmonary blastoma type 2 is more common in males than females.

3. Family history: A family history of pleuropulmonary blastoma type 2 increases the risk of developing the condition.

4. Genetic mutations: Certain genetic mutations, such as those in the TP53 gene, have been linked to an increased risk of pleuropulmonary blastoma type 2.

5. Exposure to radiation: Exposure to radiation, such as radiation therapy for other cancers, may increase the risk of pleuropulmonary blastoma type 2.

The treatment for Pleuropulmonary blastoma type 2 depends on the size and location of the tumor, as well as the age and overall health of the patient. Treatment typically involves a combination of surgery, chemotherapy, and radiation therapy. Surgery is usually the first step in treatment and may involve removing the tumor and some of the surrounding tissue. Chemotherapy and radiation therapy may be used to shrink the tumor before or after surgery. In some cases, chemotherapy may be used to shrink the tumor before surgery, and radiation therapy may be used after surgery to reduce the risk of recurrence.

Pleuropulmonary blastoma type 2 (PPB2) is a rare type of cancer that affects the lungs and chest wall. It is caused by a mutation in the gene called TP53. This mutation causes the cells in the lungs and chest wall to grow and divide uncontrollably, forming a tumor. The exact cause of this mutation is unknown, but it is believed to be related to environmental factors, such as exposure to certain chemicals or radiation.

The symptoms of Pleuropulmonary blastoma type 2 vary depending on the size and location of the tumor. Common symptoms include chest pain, shortness of breath, coughing, wheezing, and difficulty breathing. Other symptoms may include fever, weight loss, fatigue, and night sweats.

Pleuropulmonary blastoma type 2 (PPB2) is a rare type of cancer that affects the lungs and chest wall. It is a type of malignant mesenchymal tumor that usually affects children under the age of 10. It is characterized by the presence of a tumor in the pleura (the lining of the lungs) and/or the pulmonary parenchyma (the tissue of the lungs). Symptoms of PPB2 include chest pain, difficulty breathing, and coughing up blood. Treatment typically involves surgery, chemotherapy, and/or radiation therapy.